Ondansetron hydroch
Ended Awarded Last action
- Contract number
- SPE2DP25F018C
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | -$1,158 | |
| Original award | $1,158 |
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,157.70 for Ondansetron Hydrochloride under a firm fixed-price contract with the Defense Logistics Agency's Medical Supply Chain division. The award, issued on July 28, 2025, with an ultimate completion date of August 7, 2025, represents a discrete ordering action against the company's larger Indefinite Delivery Contract with the DLA. This delivery order carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal marketplace based on its established capabilities as a pharmaceutical wholesaler.
This award is issued under DMS Pharmaceutical Group's significant single-award Indefinite Delivery Contract with the DLA valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs of military health facilities worldwide. Ondansetron Hydrochloride, an anti-nausea medication commonly used in clinical settings, represents one of many pharmaceutical products the contractor supplies to Department of Defense healthcare sites. The company's substantial contract portfolio with the DLA demonstrates its critical role in the federal pharmaceutical supply chain, providing direct distribution of prescription drugs and pharmacy services to military medical facilities.
Quick answers
Who was awarded contract SPE2DP25F018C?
SPE2DP25F018C was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on July 28, 2025.
How much is contract SPE2DP25F018C worth?
The government has obligated $0 on SPE2DP25F018C.
Is contract SPE2DP25F018C an order under another contract?
Yes. SPE2DP25F018C is a delivery order under SPE2DX15D9383, an indefinite delivery contract.
Was contract SPE2DP25F018C competed?
The extent of competition for SPE2DP25F018C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award